Background: Today, more than 50% of persons with Rheumatoid Arthritis (RA) are over 65 years of age (1). Little is known about the effects of physical exercise in this age group (>65 years). Objectives: The aim of this randomized controlled study is to investigate the effects of a person-centred progressive aerobic and resistance exercise program, led by a physiotherapist. Methods: Seventy-four with persons with RA (24% men), mean age 70 years (SD 2.5), were recruited and randomized to an exercise interventions group or an active control group. The intervention consisted of a 20-week individual person-centered exercise program, performed three times a week with guidance from a physiotherapist. Both aerobic and resistance exercise was performed on a high intensity level. The control group followed a home exercise program twice a week. Muscle strength and endurance were assessed by the Chair Stands test, the Timed up and Go and a Bicycle endurance test. Maximal aerobic capacity (VO 2 max) was assessed with ergo spirometry. Activity limitations were assessed by SF36 Physical subscale and the Health Assessment Questionnaire (HAQ). Results: All participants in the intervention group completed the intervention. The participants had a low disease activity with a mean Clinical Disease Activity Index of 5.4 (SD 3.9). Significant improvements were found for VO 2 max, the Chair Stands test, the Timed up and Go, the Bicycle endurance test on bicycle (p<0,001) and the SF36 physical (p=0.018) in the intervention group, when compared to the controls. No significant differences between groups were seen on HAQ. Conclusions: Intensive progressive aerobic and resistance exercise is a feasible intervention for elderly persons with RA. Despite old age and RA the participants gained significant improvements in physical capacity.
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Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res (Hoboken Background: Fatigue is a very common symptom of primary Sjögren's syndrome (pSS), being reported by up to 70% of patients [1] . It is more pronounced when compared to healthy individuals [2] and patients often report that it is their greatest problem and the most difficult to cope with [3] . There is only one non-randomized controlled study on aerobic exercise in pSS with a small sample size suggesting improvement in fatigue, aerobic capacity, depression and physical function [4] . Objectives: To evaluate the safety and effectiveness of a supervised walking program in women with pSS. Methods: Forty five sedentary women fulfilling the American European Consensus Criteria for pSS were randomized to a Training Group (TG, n=23) or Control Group (CG, n=22). Patients in the TG were submitted to supervised walking, 3 times a week, for 16 weeks. The patients of the CG were instructed to not perform any kind of regular physical exercise. Outcomes measured were aerobic capacity, fatigue, disease activity, depression, perception of pSS's symptoms and quality of life. An intent-to-treat analysis was performed. Results: The mean change after 16 weeks of VO 2max (ml.kg -1 .min -1 ), distance and FACIT-fatigue were higher in the TG than in the CG (p=0.016, p=0.043 and p=0.030, respectively) ( Figure 1 ). Improved aerobic capacity was associated with improvements in fatigue scores and physical components of quality of life measured using SF-36. Furthermore, improved fatigue scores were associated with reduced depression and improvements in the physical and mental components of the quality of life measures. Overall, 95.4% of patients in the TG rated themselves as clinically improved versus 62% of the patients in the CG (p=0.049). There was no flare in disease activity and no serious adverse events with exercise.
Conclusions:
This supervised walking program was demonstrated to be feasible and safe with improvements in the aerobic capacity, exercise tolerance, fatigue and patient perception of improvement in pSS patients. 
